ArticleBiomedicines2022

Testosterone as a Biomarker of Adverse Clinical Outcomes in SARS-CoV-2 Pneumonia.

Lorenzo Marinelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.